|
Name | Source | Name of the source | MOA | Target and type of cancer | Reference |
|
Vincristine vinca alkaloid | Plant | Catharanthus roseus | Inhibits self assembly of microtubule and induces assembly of tubulin | Children's leukemia | [22, 23] |
Vinblastine | Plant | Catharanthus roseus | Binds to microtubule proteins in the mitotic spindle and prevents cell division during metaphase | Hodgkin's disease (lymphoid cancer) |
Etoposide | Plant | Podophyllum peltatum | Inhibits enzyme topoisomerase II in DNA replication | Testicular cancer (along bleomycin and cisplatin) | [24] |
Camptothecin quinoline alkaloid | Plant | Camptotheca acuminata | Topoisomerase I | Irinotecan and topotecan ovarian and colorectal cancer | [25] |
Paclitaxel | Plant | Taxus brevifolia | Stabilizes microtubules and leads to mitotic arrest | Ovarian, breast, and other tumors in clinic | [26, 27] |
Docetaxel | Plant | | Antineoplastic activity: I—inhibition of microtubular depolymerization II—attenuation of the effects of Bcl-2 and Bcl-xL gene expression |
Taxane | Plant | | Disruption of microtubule function | Early and metastatic breast cancer | [28] |
Homoharringtonine | Plant | Cephalotaxus harringtonii | Inhibition of protein synthesis in the ribosome of cancer cells | Chronic myeloid leukemia after failure of 2 or more tyrosine kinase inhibitors | [29] |
Ingenol mebutate | Plant | Euphorbia peplus | Protein kinase C (PKC) activator | Antileukemic | [30] |
Cytarabine | Marine | Sponge | Sugar moiety of cytarabine hinder the rotation of the molecule within the DNA. Stops replication of DNA in the S phase of cell cycle. | AME and non-Hodgkin lymphoma FDA approved | [31, 32] |
Ecteinascidin-743 (synthetic compound like sponge) | Marine | Ecteinascidia turbinata | Interacts with the minor groove of DNA and alkylates guanine at the N2 position | Metastatic breast cancer FDA approved 2010 | [33, 34] |
Dolastatin-10, (MMAE-synthetic) | Marine | Dolabella auricularia | Binds to the microtubule and prevents polymerization inhibiting the G/M phase cell cycle and apoptosis | Hodgkin’s lymphoma, systemic anaplastic large cell lymphoma, cutaneous, peripheral T-cell lymphomas FDA approved | [35] |
Eribulin | Marine | Marine sponge | Inhibition of microtubule polymerization—by binding to high-affinity sites on β-tubulin at the exposed (plus) ends of growing microtubules | Unresectable and metastatic liposarcoma FDA approved | [36] |
Eribulin mesylate | Marine | Marine sponge, Halichondria okadai | Inhibition of the growth phase of the microtubule | Metastatic breast cancer approved | [36] |
Cytosar-U | Marine | Coral reef | Interferes in DNA synthesis in cells and kills it | Leukemia and lymphoma | [37] |
5-Episinuleptolide acetate | Marine | Coral reef | This diterpenoid led to caspases-3, -8, and -9 activation as well as PARP cleavage. It also induced ROS generation, calcium accumulation, and disruption of mitochondrial membrane potential. | Leukemia | [38] |
Plitidepsin | Marine tunicates | Aplidium albicans | Inhibits proliferating cell and causes programmed cell death | Multiple myeloma FDA approved 2006 | [39] |
40-O-(2-hydroxyethyl-rapamycin | Microorganism | Streptomyces hygroscopicus | Protein kinase inhibitor and cytochrome P450 3A4 inhibitor; modulates human dendritic cell function | Pancreatic neuroendocrine tumors: FDA 2011, renal angiomyoloma with tubererous sclerosis FDA April 2012, hormone receptor-positive, HERS2-negative breast cancer FDA July 2012 | [40] |
Carfilzomib | Microorganism | Actinomycetes No. Q996-17 | Selective protease inhibitor | Relapsed and refractory multiple myeloma—FDA July 2012 | [41] |
Doxorubicin (DOX) | Microorganism | Streptomyces peucetius var. caesius | Intercalation of DOX-base pairs on the strands of the DNA, resulting in the inhibition of synthesis of DNA and transcription, the iron free radicals generated causes cellular damage to membranes, protein, and DNA | Acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms' tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, gastric carcinoma, Hodgkin's disease, malignant lymphoma, and bronchogenic carcinoma 1974 | [42] |
|